Lack of Content Uniformity in MMR Vaccine

Area of Science:

• Pharmaceutical Science
• Vaccine Quality Control
• Analytical Chemistry

Background:

• The measles, mumps, and rubella (MMR) vaccine is critical for public health, mandated for school entry in the US.
• Recent increases in measles cases and FDA concerns highlight potential issues with vaccine quality.
• Ensuring vaccine consistency is vital for maintaining herd immunity and preventing outbreaks.

Purpose of the Study:

• To investigate intra-lot and inter-lot variability in the measles, mumps, and rubella (MMR) vaccine.
• To assess the quality and consistency of MMR vaccine batches using advanced spectroscopic techniques.

Main Methods:

• Fourier transform near-infrared spectrometry (FTNIR) was employed in the Drug Quality Study (DQS).
• Spectral data from multiple vials across different lots were analyzed using subcluster detection tests.
• Statistical analysis, including standard deviations (SDs), was used to identify outliers and variability.

Main Results:

• Significant spectral variability was detected within a single lot (Merck lot U006488), with 50% of vials differing substantially.
• Analysis of a larger spectral library (198 vials, 12 lots) revealed that 30% of vials fell outside the main cluster, indicating material differences.
• These findings suggest inconsistencies in the MMR vaccine material, both within and between manufacturing lots.

Conclusions:

• The study identified significant quality variations in the MMR vaccine, challenging assumptions of lot uniformity.
• The detected variability raises concerns about the reliability and efficacy of the MMR vaccine supply.
• Further investigation into manufacturing processes and quality control measures for the MMR vaccine is warranted.